Navigating the commercial, data and regulatory challenges
Pharma’s approach to digital healthcare products is maturing. The era of experimental pilot apps is being replaced with a more sophisticated and strategic approach. Pharma firms are now looking to align digital health products with their core product portfolios with a view to achieving meaningful scale and with it, significant clinical and commercial impact.
But it’s still early days. Many companies are still on a steep learning curve about the particular challenges and complexities of getting a digital health product to market, not least among them the regulatory and legal ones.
Download this 27-page whitepaper now to:
- Explore the partnership options for creating digital health solutions and understand which model will work best for you
- Learn how to organize your teams for go-to market success with an exclusive case study from Novo Nordisk
- Understand how to navigate the regulatory maze and how to work with regulators for digital health success
- Find out how leading pharma manage data including device security and data jurisdiction – across the therapeutic lifecycle